Associated Papers
A common classification framework for histone sequence alterations in tumours: an expert consensus proposal.
Leske H et al.
The Journal of Pathology, 2021
Adult isocitrate dehydrogenase-mutant brainstem glioma: illustrative case.
Ye VC et al.
Journal of Neurosurgery. Case Lessons, 2021
Glioblastoma TCGA Mesenchymal and IGS 23 Tumors are Identifiable by IHC and have an Immune-phenotype Indicating a Potential Benefit from Immunotherapy.
Carrato C et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2020
Infratentorial IDH-mutant astrocytoma is a distinct subtype.
Banan R et al.
Acta Neuropathologica, 2020
Assessment of circulating tumor DNA in cerebrospinal fluid by whole exome sequencing to detect genomic alterations of glioblastoma.
Duan H et al.
Chinese Medical Journal, 2020
ATRX immunostaining predicts IDH and H3F3A status in gliomas.
Ebrahimi A et al.
Acta Neuropathologica Communications, 2016
27311324 (PubMed )
Supplement: 40478_2016_331_MOESM1_ESM.xls › Tabelle1
Glioblastoma: pathology, molecular mechanisms and markers.
Aldape K et al.
Acta Neuropathologica, 2015
Rare Cases of IDH1 Mutations in Spinal Cord Astrocytomas.
Konovalov NA et al.
Acta Naturae, 0
Select a paper to view details